{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["immunomodulatory and anti-inflammatory", "influenza H5N1 virus", "mesoporous silica nanoparticles", "nanoformulations-drug delivery system", "shikimic acid and quercetin natural prodrugs", "virucidal action"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32801685", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "05"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S247692"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2020"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs.", "Pagination": {"StartPage": "5181", "EndPage": "5202", "MedlinePgn": "5181-5202"}, "Abstract": {"AbstractText": ["Combating infectious diseases caused by influenza virus is a major challenge due to its resistance to available drugs and vaccines, side effects, and cost of treatment. Nanomedicines are being developed to allow targeted delivery of drugs to attack specific cells or viruses.", "In this study, mesoporous silica nanoparticles (MSNs) functionalized with amino groups and loaded with natural prodrugs of shikimic acid (SH), quercetin (QR) or both were explored as a novel antiviral nanoformulations targeting the highly pathogenic avian influenza H5N1 virus. Also, the immunomodulatory effects were investigated in vitro tests and anti-inflammatory activity was determined in vivo using the acute carrageenan-induced paw edema rat model.", "Prodrugs alone or the MSNs displayed weaker antiviral effects as evidenced by virus titers and plaque formation compared to nanoformulations. The MSNs-NH<sub>2</sub>-SH and MSNs-NH<sub>2</sub>-SH-QR2 nanoformulations displayed a strong virucidal by inactivating the H5N1 virus. They induced also strong immunomodulatory effects: they inhibited cytokines (TNF-\u03b1, IL-1\u03b2) and nitric oxide production by approximately 50% for MSNs-NH<sub>2</sub>-SH-QR2 (containing both SH and QR). Remarkable anti-inflammatory effects were observed during in vivo tests in an acute carrageenan-induced rat model.", "Our preliminary findings show the potential of nanotechnology for the application of natural prodrug substances to produce a novel safe, effective, and affordable antiviral drug."], "CopyrightInformation": "\u00a9 2020 AbouAitah et al."}, "AuthorList": [{"Identifier": ["0000-0001-8413-6738"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), P.C.12622, Dokki, Giza, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, Water Pollution Research Department, Environmental Research Division, National Research Centre (NRC) P.C.12622, Dokki, Giza, Egypt."}], "LastName": "Kandeil", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), P.C. 12622, Dokki, Giza, Egypt."}], "LastName": "Salman", "ForeName": "Asmaa M M", "Initials": "AMM"}, {"Identifier": ["0000-0002-6106-5188"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Wojnarowicz", "ForeName": "Jacek", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Scientific Excellence for Influenza Viruses, Water Pollution Research Department, Environmental Research Division, National Research Centre (NRC) P.C.12622, Dokki, Giza, Egypt."}], "LastName": "Ali", "ForeName": "Mohamed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Opalinska", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Gierlotka", "ForeName": "Stanislaw", "Initials": "S"}, {"Identifier": ["0000-0002-8726-8944"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Engineering Laboratory, Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland."}], "LastName": "Ciach", "ForeName": "Tomasz", "Initials": "T"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Drug Carriers"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Prodrugs"}, {"RegistryNumber": "29MS2WI2NU", "NameOfSubstance": "Shikimic Acid"}, {"RegistryNumber": "7631-86-9", "NameOfSubstance": "Silicon Dioxide"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Drug Carriers"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Edema"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Influenza A Virus, H5N1 Subtype"}, {"QualifierName": [], "DescriptorName": "Madin Darby Canine Kidney Cells"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Prodrugs"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Shikimic Acid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Silicon Dioxide"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16(10):8894\u20138918. doi:10.3390/molecules16108894", "ArticleIdList": ["10.3390/molecules16108894", "PMC6264685", "22024958"]}, {"Citation": "Kuiken T, Riteau B, Fouchier RA, Rimmelzwaan GF. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol. 2012;2(3):276\u2013286. doi:10.1016/j.coviro.2012.02.013", "ArticleIdList": ["10.1016/j.coviro.2012.02.013", "22709515"]}, {"Citation": "Richard M, de Graaf M, Herfst S. Avian influenza A viruses: from zoonosis to pandemic. Future Virol. 2014;9(5):513\u2013524. doi:10.2217/fvl.14.30", "ArticleIdList": ["10.2217/fvl.14.30", "PMC4157675", "25214882"]}, {"Citation": "Alam MI, Mostafa A, Kanrai P, et al. Verapamil has antiviral activities that target different steps of the influenza virus replication cycle. J Antivir Antiretrovir. 2016;8(4):121\u2013130."}, {"Citation": "Yang J, Li M, Shen X, Liu S. Influenza A virus entry inhibitors targeting the hemagglutinin. Viruses. 2013;5(1):352\u2013373. doi:10.3390/v5010352", "ArticleIdList": ["10.3390/v5010352", "PMC3564125", "23340380"]}, {"Citation": "Houser KV, Katz JM, Tumpey TM. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol. 2013;87(2):1261\u20131263. doi:10.1128/JVI.02625-12", "ArticleIdList": ["10.1128/JVI.02625-12", "PMC3554089", "23115290"]}, {"Citation": "Greber Urs F. How cells tune viral mechanics\u2014insights from biophysical measurements of influenza virus. Biophys J. 2014;106(11):2317\u20132321. doi:10.1016/j.bpj.2014.04.025", "ArticleIdList": ["10.1016/j.bpj.2014.04.025", "PMC4052274", "24896110"]}, {"Citation": "Gefenaite G, Rahamat-Langendoen J, Ambrozaitis A, et al. Seasonal influenza vaccine effectiveness against influenza in 2012\u20132013: a hospital-based case-control study in Lithuania. Vaccine. 2014;32(7):857\u2013863. doi:10.1016/j.vaccine.2013.12.021", "ArticleIdList": ["10.1016/j.vaccine.2013.12.021", "24370711"]}, {"Citation": "Valenciano M, Kissling E, Cohen J-M, et al. Estimates of pandemic influenza vaccine effectiveness in europe, 2009\u20132010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med. 2011;8(1):e1000388. doi:10.1371/journal.pmed.1000388", "ArticleIdList": ["10.1371/journal.pmed.1000388", "PMC3019108", "21379316"]}, {"Citation": "Hayden FG, de Jong MD. Emerging Influenza Antiviral Resistance Threats. J Infect Dis. 2011;203(1):6\u201310. doi:10.1093/infdis/jiq012", "ArticleIdList": ["10.1093/infdis/jiq012", "PMC3086431", "21148489"]}, {"Citation": "Cagno V, Andreozzi P, D\u2019Alicarnasso M, et al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater. 2017;17(2):195. doi:10.1038/nmat5053", "ArticleIdList": ["10.1038/nmat5053", "29251725"]}, {"Citation": "Mirza AZ, Siddiqui FA. Nanomedicine and drug delivery: a mini review. Int Nano Lett. 2014;4(1):94. doi:10.1007/s40089-014-0094-7", "ArticleIdList": ["10.1007/s40089-014-0094-7"]}, {"Citation": "Sokolova V, Westendorf AM, Buer J, Uberla K, Epple M. The potential of nanoparticles for the immunization against viral infections. J Mater Chem B. 2015;3(24):4767\u20134779. doi:10.1039/C5TB00618J", "ArticleIdList": ["10.1039/C5TB00618J", "32262665"]}, {"Citation": "Szunerits S, Barras A, Khanal M, Pagneux Q, Boukherroub R. Nanostructures for the Inhibition of Viral Infections. Molecules. 2015;20(8):14051. doi:10.3390/molecules200814051", "ArticleIdList": ["10.3390/molecules200814051", "PMC6332336", "26247927"]}, {"Citation": "Xiang D-X, Chen Q, Pang L, Zheng C-L. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011;178(1\u20132):137\u2013142. doi:10.1016/j.jviromet.2011.09.003", "ArticleIdList": ["10.1016/j.jviromet.2011.09.003", "21945220"]}, {"Citation": "Yang XX, Li CM, Huang CZ. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale. 2016;8(5):3040\u20133048. doi:10.1039/C5NR07918G", "ArticleIdList": ["10.1039/C5NR07918G", "26781043"]}, {"Citation": "Fujimori Y, Sato T, Hayata T, et al. Novel antiviral characteristics of nanosized copper(I) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus. Appl Environ Microbiol. 2012;78(4):951\u2013955. doi:10.1128/AEM.06284-11", "ArticleIdList": ["10.1128/AEM.06284-11", "PMC3272987", "22156433"]}, {"Citation": "Ye S, Shao K, Li Z, et al. Antiviral activity of graphene oxide: how sharp edged structure and charge matter. ACS Appl Mater Interfaces. 2015;7(38):21571\u201321579. doi:10.1021/acsami.5b06876", "ArticleIdList": ["10.1021/acsami.5b06876", "26370151"]}, {"Citation": "DeRussy BM, Aylward MA, Fan Z, Ray PC, Tandon R. Inhibition of cytomegalovirus infection and photothermolysis of infected cells using bioconjugated gold nanoparticles. Sci Rep. 2014;4(1):5550. doi:10.1038/srep05550", "ArticleIdList": ["10.1038/srep05550", "PMC4080223", "24989498"]}, {"Citation": "Papp I, Sieben C, Ludwig K, et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small. 2010;6(24):2900\u20132906. doi:10.1002/smll.201001349", "ArticleIdList": ["10.1002/smll.201001349", "21104827"]}, {"Citation": "Tao W, Hurst BL, Shakya AK, et al. Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. Antiviral Res. 2017;141:62\u201372. doi:10.1016/j.antiviral.2017.01.021", "ArticleIdList": ["10.1016/j.antiviral.2017.01.021", "PMC5572660", "28161578"]}, {"Citation": "Kwon S-J, Na DH, Kwak JH, et al. Nanostructured glycan architecture is important in the inhibition of influenza A virus infection. Nat Nano. 2017;12(1):48\u201354. doi:10.1038/nnano.2016.181", "ArticleIdList": ["10.1038/nnano.2016.181", "27775724"]}, {"Citation": "Ho RJ, Yu J, Li B, et al. Systems Approach to targeted and long-acting HIV/AIDS therapy. Drug Deliv Transl Res. 2015;5(6):531\u2013539. doi:10.1007/s13346-015-0254-y", "ArticleIdList": ["10.1007/s13346-015-0254-y", "PMC4826474", "26315144"]}, {"Citation": "Shao J, Kraft JC, Li B, et al. Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS. Nanomedicine. 2016;11(5):545\u2013564. doi:10.2217/nnm.16.1", "ArticleIdList": ["10.2217/nnm.16.1", "PMC4910949", "26892323"]}, {"Citation": "Sillman B, Bade AN, Dash PK, et al. Creation of a long-acting nanoformulated dolutegravir. Nat Commun. 2018;9(1):443. doi:10.1038/s41467-018-02885-x", "ArticleIdList": ["10.1038/s41467-018-02885-x", "PMC5799307", "29402886"]}, {"Citation": "Osminkina LA, Timoshenko VY, Shilovsky IP, et al. Porous silicon nanoparticles as scavengers of hazardous viruses. J Nanopart Res. 2014;16(6):2430. doi:10.1007/s11051-014-2430-2", "ArticleIdList": ["10.1007/s11051-014-2430-2"]}, {"Citation": "de Souza ESJM, Hanchuk TD, Santos MI, Kobarg J, Bajgelman MC, Cardoso MB. Viral inhibition mechanism mediated by surface-modified silica nanoparticles. ACS Appl Mater Interfaces. 2016;8(26):16564\u201316572. doi:10.1021/acsami.6b03342", "ArticleIdList": ["10.1021/acsami.6b03342", "27284685"]}, {"Citation": "Lee EC, Davis-Poynter N, Nguyen CTH, et al. GAG mimetic functionalised solid and mesoporous silica nanoparticles as viral entry inhibitors of herpes simplex type 1 and type 2 viruses. Nanoscale. 2016;8(36):16192\u201316196. doi:10.1039/C6NR03878F", "ArticleIdList": ["10.1039/C6NR03878F", "27604476"]}, {"Citation": "Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ. Mesoporous Silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc Chem Res. 2013;46(3):792\u2013801. doi:10.1021/ar3000986", "ArticleIdList": ["10.1021/ar3000986", "PMC3686852", "23387478"]}, {"Citation": "Liberman A, Mendez N, Trogler WC, Kummel AC. Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf Sci Rep. 2014;69(2\u20133):132\u2013158. doi:10.1016/j.surfrep.2014.07.001", "ArticleIdList": ["10.1016/j.surfrep.2014.07.001", "PMC4212223", "25364083"]}, {"Citation": "Heidegger S, Schmidt A, Schmidt A, et al. Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery. Nanoscale. 2016;8(2):938\u2013948.", "ArticleIdList": ["26659601"]}, {"Citation": "Shahein SA, Aboul-Enein AM, Higazy IM, et al. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Int J Nanomedicine. 2019;14:5503\u20135526. doi:10.2147/IJN.S206899", "ArticleIdList": ["10.2147/IJN.S206899", "PMC6650459", "31410001"]}, {"Citation": "AbouAitah K, Hassan HA, Swiderska-Sroda A, et al. Targeted nano-drug delivery of colchicine against colon cancer cells by means of mesoporous silica nanoparticles. Cancers. 2020;12(1):144. doi:10.3390/cancers12010144", "ArticleIdList": ["10.3390/cancers12010144", "PMC7017376", "31936103"]}, {"Citation": "Fu C, Liu T, Li L, Liu H, Chen D, Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials. 2013;34(10):2565\u20132575. doi:10.1016/j.biomaterials.2012.12.043", "ArticleIdList": ["10.1016/j.biomaterials.2012.12.043", "23332175"]}, {"Citation": "Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials. 2017;7(7):189.", "ArticleIdList": ["PMC5535255", "28737672"]}, {"Citation": "Lin Y-S, Haynes CL. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc. 2010;132(13):4834\u20134842. doi:10.1021/ja910846q", "ArticleIdList": ["10.1021/ja910846q", "20230032"]}, {"Citation": "Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro. 2005;19(7):975\u2013983. doi:10.1016/j.tiv.2005.06.034", "ArticleIdList": ["10.1016/j.tiv.2005.06.034", "16125895"]}, {"Citation": "Bradley D. Star role for bacteria in controlling flu pandemic? Nat Rev Drug Discov. 2005;4(12):945\u2013946. doi:10.1038/nrd1917", "ArticleIdList": ["10.1038/nrd1917", "16370070"]}, {"Citation": "Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Buclin T. Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza. Clin Pharmacokinet. 2010;49(11):741\u2013765. doi:10.2165/11534730-000000000-00000", "ArticleIdList": ["10.2165/11534730-000000000-00000", "20923248"]}, {"Citation": "Choi HJ, Song JH, Park KS, Kwon DH. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci. 2009;37(3\u20134):329\u2013333. doi:10.1016/j.ejps.2009.03.002", "ArticleIdList": ["10.1016/j.ejps.2009.03.002", "19491023"]}, {"Citation": "Wu W, Li R, Li X, et al. Quercetin as an antiviral agent inhibits influenza a virus (IAV) Entry. Viruses. 2016;8(1):6. doi:10.3390/v8010006", "ArticleIdList": ["10.3390/v8010006", "PMC4728566", "26712783"]}, {"Citation": "Wang G, Zhang J, Li W, et al. Apoptosis and proinflammatory cytokine responses of primary mouse microglia and astrocytes induced by human H1N1 and avian H5N1 influenza viruses. Cell Mol Immunol. 2008;5(2):113\u2013120. doi:10.1038/cmi.2008.14", "ArticleIdList": ["10.1038/cmi.2008.14", "PMC4651245", "18445341"]}, {"Citation": "Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007;81(6):2736\u20132744. doi:10.1128/JVI.02336-06", "ArticleIdList": ["10.1128/JVI.02336-06", "PMC1866007", "17182684"]}, {"Citation": "Sakabe S, Iwatsuki-Horimoto K, Takano R, et al. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol. 2011;92(Pt 6):1428\u20131434. doi:10.1099/vir.0.030346-0", "ArticleIdList": ["10.1099/vir.0.030346-0", "PMC3168279", "21367984"]}, {"Citation": "Boon AC, Williams RW, Sinasac DS, Webby RJ. A novel genetic locus linked to pro-inflammatory cytokines after virulent H5N1 virus infection in mice. BMC Genomics. 2014;15(1):1017. doi:10.1186/1471-2164-15-1017", "ArticleIdList": ["10.1186/1471-2164-15-1017", "PMC4256927", "25418976"]}, {"Citation": "Van Reeth K, Van Gucht S, Pensaert M. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol. 2002;15(4):583\u2013594. doi:10.1089/088282402320914520", "ArticleIdList": ["10.1089/088282402320914520", "12513929"]}, {"Citation": "Barbosa RPA, Salgado APC, Garcia CC, et al. Protective immunity and safety of a genetically modified influenza virus vaccine. PLoS One. 2014;9(6):e98685. doi:10.1371/journal.pone.0098685", "ArticleIdList": ["10.1371/journal.pone.0098685", "PMC4057169", "24927156"]}, {"Citation": "Shen D, Yang J, Li X, et al. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett. 2014;14(2):923\u2013932. doi:10.1021/nl404316v", "ArticleIdList": ["10.1021/nl404316v", "24467566"]}, {"Citation": "AbouAitah KEA, Farghali AA, Swiderska-Sroda A, Lojkowski W, Razin AM, Khedr MK. pH-controlled release system for curcumin based on functionalized dendritic mesoporous silica nanoparticles. J Nanomed Nanotechnol. 2016;1(351):1\u201311."}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363. doi:10.1016/0022-1759(83)90303-4", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Hayden FG, Cote KM, Douglas RG. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother. 1980;17(5):865\u2013870. doi:10.1128/AAC.17.5.865", "ArticleIdList": ["10.1128/AAC.17.5.865", "PMC283889", "7396473"]}, {"Citation": "Abdella AM, Moatasim Y, Ali MA, Elwahy AHM, Abdelhamid IA. Synthesis and anti-influenza virus activity of novel bis(4H-chromene-3-carbonitrile) Derivatives. J Heterocycl Chem. 2017;54(3):1854\u20131862. doi:10.1002/jhet.2776", "ArticleIdList": ["10.1002/jhet.2776"]}, {"Citation": "Kuo Y-C, Lin L-C, Tsai W-J, Chou C-J, Kung S-H, Ho Y-H. Samarangenin B from limonium sinense suppresses herpes simplex virus type 1 replication in vero cells by regulation of viral macromolecular synthesis. Antimicrob Agents Chemother. 2002;46(9):2854\u20132864. doi:10.1128/AAC.46.9.2854-2864.2002", "ArticleIdList": ["10.1128/AAC.46.9.2854-2864.2002", "PMC127446", "12183238"]}, {"Citation": "Zhang J, Zhan B, Yao X, Gao Y, Shong J. [Antiviral activity of tannin from the pericarp of Punica granatum L. against genital Herpes virus in vitro]. Zhongguo Zhong Yao Za Zhi. 1995;20(9):556\u2013558. Chinese.", "ArticleIdList": ["8679095"]}, {"Citation": "Schuhmacher A, Reichling J, Schnitzler P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine. 2003;10(6\u20137):504\u2013510. doi:10.1078/094471103322331467", "ArticleIdList": ["10.1078/094471103322331467", "13678235"]}, {"Citation": "Riahi-Zanjani B, Balali-Mood M, Mohammadi E, Badie-Bostan H, Memar B, Karimi G. Safranal as a safe compound to mice immune system. Avicenna j Phytomed. 2015;5(5):441\u2013449.", "ArticleIdList": ["PMC4599109", "26468464"]}, {"Citation": "McPhillips KA, Erwig LP. Assessment of apoptotic cell phagocytosis by macrophages. Methods Mol Biol. 2009;559:247\u2013256.", "ArticleIdList": ["19609761"]}, {"Citation": "Gammelsrud A, Solhaug A, Dendele B, et al. Enniatin B-induced cell death and inflammatory responses in RAW 267.4 murine macrophages. Toxicol Appl Pharmacol. 2012;261(1):74\u201387. doi:10.1016/j.taap.2012.03.014", "ArticleIdList": ["10.1016/j.taap.2012.03.014", "22483798"]}, {"Citation": "Choi YH, Kim GY, Lee HH. Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-kappaB signaling pathways. Drug Des Devel Ther. 2014;8:1941\u20131953. doi:10.2147/DDDT.S71957", "ArticleIdList": ["10.2147/DDDT.S71957", "PMC4206205", "25342887"]}, {"Citation": "Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci. 2005;1056(1):218\u2013233. doi:10.1196/annals.1352.026", "ArticleIdList": ["10.1196/annals.1352.026", "16387690"]}, {"Citation": "Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126(1):131\u2013138. doi:10.1016/0003-2697(82)90118-X", "ArticleIdList": ["10.1016/0003-2697(82)90118-X", "7181105"]}, {"Citation": "Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003;225:115\u2013121.", "ArticleIdList": ["12769480"]}, {"Citation": "Arfan M, Amin H, Khan N, et al. Analgesic and anti-inflammatory activities of 11-O-galloylbergenin. J Ethnopharmacol. 2010;131(2):502\u2013504. doi:10.1016/j.jep.2010.06.040", "ArticleIdList": ["10.1016/j.jep.2010.06.040", "20603209"]}, {"Citation": "Li Z, Su K, Cheng B, Deng Y. Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery. J Colloid Interface Sci. 2010;342(2):607\u2013613. 10.1016/j.jcis.2009.10.073", "ArticleIdList": ["10.1016/j.jcis.2009.10.073", "19948346"]}, {"Citation": "AbouAitah KEA, Farghali AA, Swiderska-Sroda A, Lojkowski W, Razin AM, Khedr MK. Mesoporous silica materials in drug delivery system: ph/glutathione-responsive release of poorly water-soluble pro-drug quercetin from two and three-dimensional pore-structure nanoparticles. J Nanomed Nanotechnol. 2016;1(360):1\u201312. doi:10.4172/2157-7439.1000360", "ArticleIdList": ["10.4172/2157-7439.1000360"]}, {"Citation": "Popova M, Szegedi A, Yoncheva K, et al. New method for preparation of delivery systems of poorly soluble drugs on the basis of functionalized mesoporous MCM-41 nanoparticles. Microporous Mesoporous Mater. 2014;198:247\u2013255. doi:10.1016/j.micromeso.2014.07.044", "ArticleIdList": ["10.1016/j.micromeso.2014.07.044"]}, {"Citation": "AbouAitah K, Swiderska-Sroda A, Farghali AA, et al. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action. Oncotarget. 2018;9(41):26466\u201326490. doi:10.18632/oncotarget.25470", "ArticleIdList": ["10.18632/oncotarget.25470", "PMC5995188", "29899871"]}, {"Citation": "Horcajada P, R\u00e1mila A, F\u00e9rey G, Vallet-Reg\u00ed M. Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci. 2006;8(10):1243\u20131249. doi:10.1016/j.solidstatesciences.2006.04.016", "ArticleIdList": ["10.1016/j.solidstatesciences.2006.04.016"]}, {"Citation": "Jambhrunkar S, Qu Z, Popat A, et al. Effect of Surface Functionality of Silica Nanoparticles on Cellular Uptake and Cytotoxicity. Mol Pharm. 2014;11(10):3642\u20133655. doi:10.1021/mp500385n", "ArticleIdList": ["10.1021/mp500385n", "25166282"]}, {"Citation": "Datt A, El-Maazawi I, Larsen SC. Aspirin loading and release from MCM-41 Functionalized with aminopropyl groups via co-condensation or postsynthesis modification methods. J Phys Chem C. 2012;116(34):18358\u201318366. doi:10.1021/jp3063959", "ArticleIdList": ["10.1021/jp3063959"]}, {"Citation": "Guo Z, Liu X-M, Ma L, et al. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement. Colloids Surf B Biointerfaces. 2013;101:228\u2013235. doi:10.1016/j.colsurfb.2012.06.026", "ArticleIdList": ["10.1016/j.colsurfb.2012.06.026", "23010024"]}, {"Citation": "Song SW, Hidajat K, Kawi S. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix\u2212drug interactions. Langmuir. 2005;21(21):9568\u20139575. doi:10.1021/la051167e", "ArticleIdList": ["10.1021/la051167e", "16207037"]}, {"Citation": "Lee C-H, Lo L-W, Mou C-Y, Yang C-S. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv Funct Mater. 2008;18(20):3283\u20133292. doi:10.1002/adfm.200800521", "ArticleIdList": ["10.1002/adfm.200800521"]}, {"Citation": "Wani A, Muthuswamy E, Savithra GHL, Mao G, Brock S, Oupick\u00fd D. Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm Res. 2012;29(9):2407\u20132418. doi:10.1007/s11095-012-0766-9", "ArticleIdList": ["10.1007/s11095-012-0766-9", "22555380"]}, {"Citation": "Yoncheva K, Popova M, Szegedi A, et al. Functionalized mesoporous silica nanoparticles for oral delivery of budesonide. J Solid State Chem. 2014;211:154\u2013161. doi:10.1016/j.jssc.2013.12.020", "ArticleIdList": ["10.1016/j.jssc.2013.12.020"]}, {"Citation": "Baghirov H, Karaman D, Viitala T, et al. Feasibility study of the permeability and uptake of mesoporous silica nanoparticles across the blood-brain barrier. PLoS One. 2016;11(8):e0160705. doi:10.1371/journal.pone.0160705", "ArticleIdList": ["10.1371/journal.pone.0160705", "PMC4993362", "27547955"]}, {"Citation": "Ge Q, Pastey M, Kobasa D, et al. Inhibition of multiple subtypes of influenza a virus in cell cultures with morpholino oligomers. Antimicrob Agents Chemother. 2006;50(11):3724\u20133733. doi:10.1128/AAC.00644-06", "ArticleIdList": ["10.1128/AAC.00644-06", "PMC1635187", "16966399"]}, {"Citation": "Chen D-Y, Shien J-H, Tiley L, et al. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010;119(4):1346\u20131351. doi:10.1016/j.foodchem.2009.09.011", "ArticleIdList": ["10.1016/j.foodchem.2009.09.011"]}, {"Citation": "El-Sherif O, Khoo S, Solas C. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection. Curr Opin HIV AIDS. 2015;10(5):348\u2013354. doi:10.1097/COH.0000000000000185", "ArticleIdList": ["10.1097/COH.0000000000000185", "26248122"]}, {"Citation": "Schmidtke M, Schnittler U, Jahn B, Dahse HM, Stelzner A. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J Virol Methods. 2001;95(1\u20132):133\u2013143. doi:10.1016/S0166-0934(01)00305-6", "ArticleIdList": ["10.1016/S0166-0934(01)00305-6", "11377720"]}, {"Citation": "Baer A, Kehn-Hall K. Viral concentration determination through plaque assays: using traditional and novel overlay systems. J Visualized Exp. 2014;93:e52065.", "ArticleIdList": ["PMC4255882", "25407402"]}, {"Citation": "Estevez AM, Estevez RJ. A short overview on the medicinal chemistry of (-)-shikimic acid. Mini Rev Med Chem. 2012;12(14):1443\u20131454. doi:10.2174/138955712803832735", "ArticleIdList": ["10.2174/138955712803832735", "22827174"]}, {"Citation": "Palamara AT, Nencioni L, Aquilano K, et al. Inhibition of influenza A virus replication by resveratrol. J Infect Dis. 2005;191(10):1719\u20131729. doi:10.1086/429694", "ArticleIdList": ["10.1086/429694", "15838800"]}, {"Citation": "Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6(1):197. doi:10.1186/1743-422X-6-197", "ArticleIdList": ["10.1186/1743-422X-6-197", "PMC2785784", "19912623"]}, {"Citation": "Baram-Pinto D, Shukla S, Gedanken A, Sarid R. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small. 2010;6(9):1044\u20131050. doi:10.1002/smll.200902384", "ArticleIdList": ["10.1002/smll.200902384", "20394070"]}, {"Citation": "Ghosh S, Chisti Y, Banerjee UC. Production of shikimic acid. Biotechnol Adv. 2012;30(6):1425\u20131431. doi:10.1016/j.biotechadv.2012.03.001", "ArticleIdList": ["10.1016/j.biotechadv.2012.03.001", "22445787"]}, {"Citation": "Li Y, Lin Z, Zhao M, et al. Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 Influenza Virus through ROS-mediated signaling pathways. ACS Appl Mater Interfaces. 2016;8(37):24385\u201324393. doi:10.1021/acsami.6b06613", "ArticleIdList": ["10.1021/acsami.6b06613", "27588566"]}, {"Citation": "Lankoff A, Arabski M, Wegierek-Ciuk A, et al. Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology. 2013;7(3):235\u2013250. doi:10.3109/17435390.2011.649796", "ArticleIdList": ["10.3109/17435390.2011.649796", "22264124"]}, {"Citation": "Heidegger S, Gossl D, Schmidt A, et al. Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery. Nanoscale. 2016;8(2):938\u2013948. doi:10.1039/C5NR06122A", "ArticleIdList": ["10.1039/C5NR06122A", "26659601"]}, {"Citation": "Ai W, Li H, Song N, Li L, Chen H. Optimal Method to Stimulate Cytokine Production and Its Use in Immunotoxicity Assessment. Int J Environ Res Public Health. 2013;10(9):3834\u20133842. doi:10.3390/ijerph10093834", "ArticleIdList": ["10.3390/ijerph10093834", "PMC3799516", "23985769"]}, {"Citation": "Boscolo P, Del Signore A, Sabbioni E, et al. Effects of resveratrol on lymphocyte proliferation and cytokine release. Ann Clin Lab Sci. 2003;33(2):226\u2013231.", "ArticleIdList": ["12817628"]}, {"Citation": "Munoz-Culla M, Saenz-Cuesta M, Guereca-Barandiaran MJ, Ribeiro ML, Otaegui D. Yerba mate (Ilex paraguariensis) inhibits lymphocyte activation in vitro. Food Funct. 2016;7(11):4556\u20134563. doi:10.1039/C6FO01061J", "ArticleIdList": ["10.1039/C6FO01061J", "27714004"]}, {"Citation": "Przybylski S, Gasch M, Marschner A, et al. Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo. PLoS One. 2017;12(5):e0176517. doi:10.1371/journal.pone.0176517", "ArticleIdList": ["10.1371/journal.pone.0176517", "PMC5412997", "28463994"]}, {"Citation": "De la Fuente M, Victor VM. Anti-oxidants as modulators of immune function. Immunol Cell Biol. 2000;78(1):49\u201354. doi:10.1046/j.1440-1711.2000.00884.x", "ArticleIdList": ["10.1046/j.1440-1711.2000.00884.x", "10651929"]}, {"Citation": "Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343(5):338\u2013344. doi:10.1056/NEJM200008033430506", "ArticleIdList": ["10.1056/NEJM200008033430506", "10922424"]}, {"Citation": "Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782\u2013787. doi:10.1038/35021228", "ArticleIdList": ["10.1038/35021228", "10963608"]}, {"Citation": "Chan RWY, Leung CYH, Nicholls JM, Peiris JSM, Chan MCW. Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses. PLoS One. 2012;7(11):e51057. doi:10.1371/journal.pone.0051057", "ArticleIdList": ["10.1371/journal.pone.0051057", "PMC3511392", "23226456"]}, {"Citation": "Nain M, Hinder F, Gong JH, et al. Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol. 1990;145(6):1921\u20131928.", "ArticleIdList": ["2391423"]}, {"Citation": "Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 1997;22(12):477\u2013481. doi:10.1016/S0968-0004(97)01147-X", "ArticleIdList": ["10.1016/S0968-0004(97)01147-X", "9433128"]}, {"Citation": "Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB j. 1992;6(12):3051\u20133064. doi:10.1096/fasebj.6.12.1381691", "ArticleIdList": ["10.1096/fasebj.6.12.1381691", "1381691"]}, {"Citation": "Gao Y, Jiang W, Dong C, et al. Anti-inflammatory effects of sophocarpine in LPS-induced RAW 264.7 cells via NF-kappaB and MAPKs signaling pathways. Toxicol Vitro. 2012;26(1):1\u20136. doi:10.1016/j.tiv.2011.09.019", "ArticleIdList": ["10.1016/j.tiv.2011.09.019", "21978812"]}, {"Citation": "Rabelo TK, Guimaraes AG, Oliveira MA, et al. Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice. Int Immunopharmacol. 2016;39:97\u2013105. doi:10.1016/j.intimp.2016.07.016", "ArticleIdList": ["10.1016/j.intimp.2016.07.016", "27454847"]}, {"Citation": "Manna K, Khan A, Das D, et al. Protective effect of coconut water concentrate and its active component shikimic acid against hydroperoxide mediated oxidative stress through suppression of NF-\u03baB and activation of Nrf2 pathway. J Ethnopharmacol. 2014;155(1):132\u2013146. doi:10.1016/j.jep.2014.04.046", "ArticleIdList": ["10.1016/j.jep.2014.04.046", "24835026"]}, {"Citation": "Lloberas J, Valverde-Estrella L, Tur J, Vico T, Celada A. Mitogen-activated protein kinases and mitogen kinase phosphatase 1: a critical interplay in macrophage biology. Fron Mol Biosci. 2016;3:28. doi:10.3389/fmolb.2016.00028", "ArticleIdList": ["10.3389/fmolb.2016.00028", "PMC4923182", "27446931"]}, {"Citation": "Kumar RP, Abraham A. Inhibition of LPS induced pro-inflammatory responses in RAW 264.7 macrophage cells by PVP-coated naringenin nanoparticle via down regulation of NF-kappaB/P38MAPK mediated stress signaling. Pharmacol Rep. 2017;69(5):908\u2013915. doi:10.1016/j.pharep.2017.04.002", "ArticleIdList": ["10.1016/j.pharep.2017.04.002", "28624598"]}, {"Citation": "Qureshi AA, Tan X, Reis JC, et al. Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models. Lipids Health Dis. 2011;10(1):177. doi:10.1186/1476-511X-10-177", "ArticleIdList": ["10.1186/1476-511X-10-177", "PMC3206449", "21992595"]}, {"Citation": "Nair MP, Mahajan S, Reynolds JL, et al. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-\u03ba\u03b2 System. Clin Vaccine Immunol. 2006;13(3):319\u2013328. doi:10.1128/CVI.13.3.319-328.2006", "ArticleIdList": ["10.1128/CVI.13.3.319-328.2006", "PMC1391952", "16522772"]}, {"Citation": "Liu Y, Hardie J, Zhang X, Rotello VM. Effects of engineered nanoparticles on the innate immune system. Semin Immunol. 2017;34:25\u201332. doi:10.1016/j.smim.2017.09.011", "ArticleIdList": ["10.1016/j.smim.2017.09.011", "PMC5705289", "28985993"]}, {"Citation": "Bains BK, Greene MK, McGirr LM, Dorman J, Farrow SN, Scott CJ. Encapsulation of the p38 MAPK inhibitor GSK 678361A in nanoparticles for inflammatory-based disease states. J Interdiscip Nanomed. 2016;1(3):85\u201392. doi:10.1002/jin2.9", "ArticleIdList": ["10.1002/jin2.9"]}, {"Citation": "Rachmawati H, Safitri D, Pradana AT, Adnyana IK. TPGS-stabilized curcumin nanoparticles exhibit superior effect on carrageenan-induced inflammation in wistar rat. Pharmaceutics. 2016;8(3):24. doi:10.3390/pharmaceutics8030024", "ArticleIdList": ["10.3390/pharmaceutics8030024", "PMC5039443", "27537907"]}, {"Citation": "Xu X, Zhao C, Yang H, Jian Y, Zhang Z, Huang Y. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers. Drug Deliv. 2011;18(7):485\u2013492. doi:10.3109/10717544.2011.589087", "ArticleIdList": ["10.3109/10717544.2011.589087", "21692681"]}]}], "History": [{"Year": "2020", "Month": "1", "Day": "30"}, {"Year": "2020", "Month": "6", "Day": "2"}, {"Year": "2020", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["32801685", "PMC7398888", "10.2147/IJN.S247692", "247692"]}}]}